Back to Results
First PageMeta Content
Enterobacteria / Molecular biology / Laboratory techniques / Polymerase chain reaction / Gram-negative bacteria / Beta-lactamase / Klebsiella pneumoniae / Ertapenem / Antibiotic resistance / Bacteria / Biology / Chemistry


Limited diversity in the gene pool allows prediction of third-generation cephalosporin and aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae
Add to Reading List

Document Date: 2013-11-10 23:24:11


Open Document

File Size: 288,31 KB

Share Result on Facebook

City

Westmead / Hilden / Boston / Liverpool / Sydney / Wayne / Basingstoke / Phoenix / Darlinghurst / Washington / Adelaide / /

Company

16S rRNA / Immunetics Inc. / LG / GenBank / Elsevier B.V. / Pall Corporation / Smeets LC / QIAGEN / Coleman NV / Becton Dickinson / bioMérieux Diagnostics / GE Healthcare / Suzuki / Weng LC / Oxoid Ltd. / /

Continent

South America / /

Country

Germany / France / Japan / United States / Brazil / Canada / Australia / United Kingdom / China / /

/

Facility

Sichuan University / Royal Prince Alfred Hospital / Westmead Hospital / Port Washington / Liverpool Hospital / Concord Hospital / University of Sydney / Wales Hospital / Westmead Millennium Institute / St Vincent’s Hospital / West China Hospital / Laboratory Standards Institute / Nepean Hospital / Sydney Institute / /

/

IndustryTerm

clinical microbiological applications / residual probe solutions / minimal infrastructure / surveillance tool / epidemiological and diagnostic tool / prediction algorithm / /

MedicalCondition

DF / JE / E. cloacae K. pneumoniae E. cloacae K. pneumoniae Pseudomonas / useful infection / severe sepsis / septic shock / 2× SSPE / serious sepsis / sepsis / hypotension / native Pseudomonas / infectious disease / human septic shock / /

MedicalTreatment

antibiotics / /

NaturalFeature

NPV falls / /

Organization

National Health and Medical Research Council of Australia / Liverpool Hospital / Division of Microbiology / Wales Hospital / Sydney South West Pathology Service / West China Hospital / International Society of Chemotherapy / Department of Pathology / Department of Microbiology and Infectious Diseases / University of Sydney / Clinical and Laboratory Standards Institute / University of Sydney / Sydney / Bradford PA / Sichuan University / Chengdu / Critical Infection and Sydney Institute for Emerging Infections and Biosecurity / Australia Centre for Research Excellence / Department of Microbiology / St Vincent’s Hospital / Concord Hospital / Westmead Millennium Institute / Sydney West Area Health Service / Nepean Hospital / Westmead Hospital / European Committee on Antimicrobial Susceptibility Testing / Royal Prince Alfred Hospital / Centre for Infectious Diseases / Department of Infectious Diseases / /

Person

Jan Bell / Prince / Sally R. Partridge / Sydney West / J. Bell J. Bell / Thomas Gottlieb / Andrew N. Ginn / John Merlino / Elaine Cheong / Marcel J. Leroi / Jonathan R. Iredell / Sydney M. Bell / Microbiology / John Turnidge / /

/

Position

Corresponding author / Prince / /

Product

gentamicin / M14 / Remington m24 / tobramycin / ceftazidime / M-9 / acetic acid / cefotaxime / genesa / ceftriaxone / /

ProvinceOrState

New York / New South Wales / /

Region

South Wales / West China / /

Technology

hybridization / prediction algorithm / Chemotherapy / Recombination / /

URL

http /

SocialTag